Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients With Ataxia Telangiectasia

Trial Profile

Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients With Ataxia Telangiectasia

Recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Aug 2017

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Ataxia telangiectasia
  • Focus Registrational; Therapeutic Use
  • Acronyms ATTEST
  • Sponsors EryDel
  • Most Recent Events

    • 06 Mar 2017 Status changed from not yet recruiting to recruiting, according to an EryDel media release.
    • 20 Jan 2017 Planned End Date changed from 1 Dec 2018 to 1 Mar 2019.
    • 20 Jan 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Aug 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top